More information: Mohamed Adil et al, Preeclampsia risk prediction from prenatal cell-free DNA screening, Nature Medicine (2025). DOI: 10.1038/s41591-025-03509-w Provided by University of ...

The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Cell-free fetal DNA testing: Some of your baby’s DNA winds up in your blood. After 10 weeks, your doctor takes a sample from you, and a lab tests the baby’s DNA in it for signs of: Down syndrome ...

The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market ...

Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S ...

NIPT works by testing all the cell-free DNA circulating in the mother's blood. Most of the DNA comes from the mother. Only 10% to 20% of it comes from the baby.

Cell-Free Fetal DNA Testing MarketThe global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million ...

For example, stomach cancer is expected in about 100 people among 100,000 Americans between the ages of 50-70. The test is expected to find roughly 30% of them, so 30 people out of 100,000 will be ...

A new blood test utilizing cell-free DNA from the placenta can predict preterm preeclampsia with 80% accuracy. This condition, causing significant maternal and fetal mortality, has been difficult ...